Publicaciones en colaboración con investigadores/as de Philipp University of Marburg (23)

2023

  1. The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus

    eClinicalMedicine, Vol. 61

  2. The MooDFooD randomized controlled trial: the data and its implications for the theory

    Psychological Medicine

  3. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    Annals of Oncology

2022

  1. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

    The Lancet Oncology, Vol. 23, Núm. 8, pp. e374-e384

  2. There is not much to mediate [yet] when it comes to diet and depression

    Molecular Psychiatry

2021

  1. Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox

    The Lancet Oncology, Vol. 22, Núm. 1, pp. e18-e28

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 439-448

2019

  1. Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

    International Journal of Gynecological Cancer, Vol. 29, Núm. 7, pp. 1141-1147

2018

  1. Treatable inherited rare movement disorders

    Movement Disorders, Vol. 33, Núm. 1, pp. 21-35

2017

  1. Brief Report about the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer from Spiliotis et al

    International Journal of Gynecological Cancer, Vol. 27, Núm. 2, pp. 246-247

2016

  1. Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)

    Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2516-2525

  2. Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology

    Experimental Dermatology, Vol. 25, Núm. 11, pp. 839-846

  3. Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial

    International Journal of Gynecological Cancer, Vol. 26, Núm. 5, pp. 898-905

2014

  1. Multicenter study of descemet membrane endothelial keratoplasty: First case series of 18 surgeons

    JAMA Ophthalmology, Vol. 132, Núm. 10, pp. 1192-1198

  2. The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner

    Journal of Biological Chemistry, Vol. 289, Núm. 22, pp. 15495-15506

2013

  1. Suicidal ideation in a European Huntington's disease population

    Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258

2012

  1. GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells

    Cancer Research, Vol. 72, Núm. 1, pp. 88-99

  2. GLI1 modulates EMT in pancreatic cancer - Response

    Cancer Research

2007

  1. A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population

    Clinical Endocrinology, Vol. 66, Núm. 5, pp. 652-658